Clinical data from the SURMOUNT trials confirms that tirzepatide dual mechanism produces greater weight loss than semaglutide GLP-1-only approach
Direct answer: Prolonged fullness means the stomach still feels full many hours after a meal should have moved forward
Clinicians advise immediate medical evaluation and temporary discontinuation of GLP-1 therapy pending workup if pancreatitis is suspected
Tirzepatide represents a shift in how the medical field treats weight reduction
If you develop a widespread rash, urticaria, or any rash accompanied by breathing difficulties, facial swelling, or feeling unwell, discontinue tirzepatide immediately and seek urgent medical advice
Current standard management approaches include medical therapies such as acetazolamide, which reduces cerebrospinal fluid (CSF) production, topiramate, which combines ICP-lowering and migraine prophylaxis effects, and other diuretics [2, 3]